Landfar(000504.SZ)

Last Updated 00:00:00
longbridge loading
Company Encyclopedia
View More
name
Landfar
000504.SZ
Landfar Bio-medicine Co., Ltd operates as a biomedical technology company. It operates in two segments, Biomedicine, and Energy Saving and Environmental Protection. The Biomedicine segment engages in the provision of stem cell, immune cell storage and technical services, and medical device trade. The Energy Saving and Environmental Protection segment is involved in the external energy management contract energy management business; build-transfer business and sales of related products; and sewage treatment business.
1.470 T
000504.SZMarket value -Rank by Market Cap -/-

Financial Score

20/05/2026 Update
B
BiotechnologyIndustry
Industry Ranking18/81
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreB
    • ROE16.47%A
    • Profit Margin8.22%B
    • Gross Margin20.46%D
  • Growth ScoreA
    • Revenue YoY291.66%A
    • Net Profit YoY318.45%A
    • Total Assets YoY68.87%A
    • Net Assets YoY34.09%A
  • Cash ScoreC
    • Cash Flow Margin-487.83%E
    • OCF YoY291.66%A
  • Operating ScoreB
    • Turnover0.63B
  • Debt ScoreD
    • Gearing Ratio63.69%D

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Telomir Reports Peer-Reviewed Preclinical Telomir-Zn Data Showing Dose-Dependent Survival & Reduced Hepatic Copper

    TradingView·
    US
    TELO
    +4.92%
    US
    ARKG
    +3.56%
    US
    FBT
    +1.40%
    TradingView·
    US
    TELO
    +4.92%
    US
    ARKG
    +3.56%
    US
    FBT
    +1.40%

    ST Landfar plans to acquire 51% equity of Huize Pharmaceutical, which is expected to constitute a significant asset restructuring situation

    Zhitong·
    SZ
    000504
    +1.52%
    Zhitong·
    SZ
    000504
    +1.52%

    Overview of the lifting of restrictions on the sale of A-shares | July 10

    Zhitong·
    SZ
    300001
    +0.40%
    SZ
    000504
    +1.52%
    Zhitong·
    SZ
    300001
    +0.40%
    SZ
    000504
    +1.52%

    ST Landfar plans to list the sale of a 52% stake in its subsidiary Nanhua Heping

    Zhitong·
    SZ
    000504
    +1.52%
    Zhitong·
    SZ
    000504
    +1.52%

    The ST sector strengthened, with over 20 stocks hitting the daily limit up

    Zhitong·
    SZ
    002620
    -5.03%
    SZ
    000504
    +1.52%
    SH
    688287
    -6.67%
    Zhitong·
    SZ
    002620
    -5.03%
    SZ
    000504
    +1.52%
    SH
    688287
    -6.67%
    © 2026 Longbridge｜Disclaimer